Cellulitis and Soft Tissue Infections Author: Dennis L. Stevens, PhD, MD; Lawrence J. Eron, MD, FACP
Editorial changes - 2008-08-20
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
What's New
New Information
2007-01-18FDA Clears First Quick Test For Drug-Resistant Staph Infections

Newly Cited References
2008-06-01Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
2008-05-01Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis.
2008-04-26Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial.
2008-04-24Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
2008-04-01Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
2008-03-18Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
2008-02-15Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic.
2008-02-19Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.
2008-01-01Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.
2005-12-01The role of nasal carriage in Staphylococcus aureus infections.
2005-12-01Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
2004-08-21Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.
2003-12-01Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria.

New References of Interest
2008-07-28National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.
2008-05-07Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.
FAQs
Dennis L. Stevens, PhD, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Lawrence J. Eron, MD, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.